• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Masuda Hiroko  増田 紘子

ORCIDConnect your ORCID iD *help
Researcher Number 90549875
Other IDs
Affiliation (Current) 2025: 地方独立行政法人東京都立病院機構東京都立駒込病院(臨床研究室), 乳腺外科, 医長
2025: 昭和大学, 医学部, 兼任講師
Affiliation (based on the past Project Information) *help 2025: 昭和大学, 医学部, 講師
2019 – 2023: 昭和大学, 医学部, 講師
2016 – 2018: 昭和大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 55010:General surgery and pediatric surgery-related / Human pathology
Keywords
Principal Investigator
classification / TNBC / Target therapy / Immune signature / mRNA analysis / Immune system / subtype / RNA-seq / Classification / breast cancer … More / RNA sequencing / predictive marker / Immune syste / breast cancer / RNA sequencing / predictive marker / ICI Immune syste / IO score / ICI / Immune Biomarker / Immune system / TNBC molecular subtype / 網羅的遺伝子解析 / 乳腺外科学 / マイクロアレイ / 遺伝子病理診断学 / morphological subtype / Heterogenity / Subtype / gene profiling / 病理形態学的分類 / Triple Negative乳がん / mRNA profiling / classificarion / heterogeneity / mRNA profiling / target therapy / heterogeity Less
  • Research Projects

    (3 results)
  • Research Products

    (10 results)
  •  IO score及び腸内細菌叢の経時的評価に基づく周術期乳がん免疫活性評価の確立Principal Investigator

    • Principal Investigator
      増田 紘子
    • Project Period (FY)
      2025 – 2028
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Showa University
  •  Insight TNBCtypeによるsubtype/分子標的薬治療の確立Principal Investigator

    • Principal Investigator
      増田 紘子
    • Project Period (FY)
      2019 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 55010:General surgery and pediatric surgery-related
    • Research Institution
      Showa University
  •  Challenges to the construction of therapeutic strategies based on triple negative breast cancer molecular subtypes by clinicopathological and morphological features.Principal Investigator

    • Principal Investigator
      Masuda Hiroko
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Human pathology
    • Research Institution
      Showa University

All 2023 2018

All Presentation

  • [Presentation] The biological characteristics of HER2-low in TNBC using mRNA profiling and molecular subtypes2023

    • Author(s)
      Asako Tsuruga, Masahiro Hosonuma, Aya Sasaki, Hikaru Isobe, Napa Parinyanitikul, Gyungyub Gong, Hee Jin Lee, Reika YOSHIDA, Naoki Hayashi, Seigo Nakamura, Robert Seitz, David Hout, Naoto T. Ueno, Hiroko Masuda
    • Organizer
      ESMO Asia
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K18071
  • [Presentation] The development of TNBC treatment through overcoming heterogeneity2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      第16回日本臨床腫瘍学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Apocrine morphology and luminal androgen receptor (LAR) molecular subtype predict prognosis of patients with residual triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      San Antonio Breast Cancer Symposium 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Molecular subtypes of Triple-negative breast cancer(TNBC) tumor samples obtained before and after neoadjuvant systemic therapy(NST) and relationship between immunomodulatory(IM) gene signature and intensity of tumor-infiltrating lymphocytes(TILs)2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      米国腫瘍学会ASCO
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] The development of TNBC treatment through overcoming heterogeneity2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      第16回日本臨床腫瘍学会学術総会
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Reversephaseproteinarray(RPPA)とmRNAMicroarrayによるTriplenegativebreastcancersubtypeの比較2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      第26回日本乳がん学会学術総会
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Comparison of molecular subtypes of triple-negative breast cancer derived from reverse-phase protein arrays and mRNA analysis2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      GBCC
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Comparison of molecular subtypes of triple-negative breast cancer derived from reverse-phase protein arrays and mRNA analysis2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      Asian Breast Cancer Society Global Breast Cancer Conference,
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Molecular subtypes of triple-negative breast cancer (TNBC) tumor samples obtained before and after neoadjuvant systemic therapy (NST) and relationship between immunomodulatory (IM) gene signature and intensity of tumor-infiltrating lymphocytes (TILs)2018

    • Author(s)
      Hiroko Masuda
    • Organizer
      ASCO annual meeting 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21374
  • [Presentation] Reverse phase protein array (RPPA)とmRNA MicroarrayによるTriple Negative Breast Cancer subtypeの比較2018

    • Author(s)
      増田 紘子
    • Organizer
      第26回日本乳がん学会学術総会
    • Data Source
      KAKENHI-PROJECT-16K21374

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi